Quantitation of prothrombin activation products in human urine.
Urine samples obtained from 37 normal individuals have been screened for the presence of prothrombin activation products using radioimmunoassays developed for fragment 1, fragment 2 and prothrombin derivatives bearing the thrombin region. The cross-reacting materials detected in urine were isolated by affinity chromatography on insolubilized antibodies, and analysed by SDS polyacrylamide gel electrophoresis. The only prothrombin derivatives detected were fragment 1 (37/37) and fragment 2 (22/37). The mean values of daily urinary fragment 1 and fragment 2 excretion were respectively 13.4 nM and 1.5 nM. The excretion of prothrombin derivatives has been quantitated in 14 normal pregnant women, during the third trimester of gestation. The mean values of urinary excretion were 47.2 nM per day for fragment 1 (P less than 0.005) and 6.4 nM per day for fragment 2 (P less than 0.05). The significant increase in fragment 1 and fragment 2 excretion observed in a condition known to be associated with the so-called hypercoagulable state suggest that the measurement of prothrombin derivatives in urine could be a useful tool for the non-invasive detection of thromboembolic diseases or prethrombotic states.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002846:Chromatography, Affinity; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000652:urine*; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011498:Protein Precursors; D011516:Prothrombin / Q000652:urine*; D011863:Radioimmunoassay
D010446:Peptide Fragments; D011498:Protein Precursors; C029733:prothrombin fragment 1; C044183:prothrombin fragment 2; D011516:Prothrombin